Type : Bid Notification
Metro Health is seeking at least 10 agencies to provide outreach services to mitigate vaccine hesitancy and build vaccine confidence in areas in Bexar County with low immunization coverage.
Metro Health is seeking at least 10 agencies to provide outreach services to mitigate vaccine hesitancy and build vaccine confidence in areas in Bexar County with low immunization coverage.
REFERENCE NUMBER: 34056 Purchasing Agency: MMCAP Infuse Solicitation Number: MS20240004 Title: Distribution of Vaccines and Vaccine-related ProductsContract Available to: MMCAP Infuse Member FacilitiesResponse to this solicitation is due no later than: 04/30/24 at 2:00pm (Central) MMCAP Infuse has released a solicitation titled Request for Proposals (RFP) for Distribution of Vaccines and Vaccine-related Products.
The contractor shall provide medical expert services and medical review /case managers for the National Vaccine Injury Compensation Program (VICP).
0000027861 California Vaccine Management Solution (CA-VMS) Maintenance & Operations Department of Public Health 09/30/2024 3:00PM PDT Posted
Project: RFP-9124 - Evaluation to Combat Vaccine Misinformation and Hesitancy Ref. #: RFP-9124 - Evaluation to Combat Vaccine Misinformation and Hesitancy Type: RFP Status: Open Open Date: Mar 28th 2024, 9:00 AM EDT Questions Due Date: May 1st 2024, 10:00 AM EDT Close Date: May 8th 2024, 11:30 AM EDT Days Left: 7 Project Description:Allegheny County is looking for a proposer to evaluate and make an assessment of vaccine hesitancy.
VACCINE STORAGE AND ROTATION Solicitation ID/Procurement Identifier: 75D30120Q71177 Ultimate Completion Date: Sun Jun 30 17:00:00 GMT 2024
These broadly include the following:• USDA seeks manufacturers with the capability to produce vaccine or vaccine precursors suitable for use in horses targeting the FAD: JEV, AHS, Hendra virus, and Nipah virus, as well as diagnostic tests associated with these vaccines that could differentiate vaccinated from infected animals.• USDA seeks manufacturers with the capacity for ongoing vaccine or vaccine precursor and diagnostic test production in the